Atlas FDA

Dexcon G5 Mobile Continuous Glucose Monitoring System

FDA premarket approval P120005/S065 · decided 2017-09-21

Approval details

PMA number
P120005
Supplement
S065
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Dexcon G5 Mobile Continuous Glucose Monitoring System
Generic name
Sensor, glucose, invasive, non-adjunctive
Applicant
Dexcom, Inc.
Date received
2017-07-10
Decision date
2017-09-21
Days to decision
73 days
Decision code
APPR
Product code
PQF
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Approval for firmware modifications to the touchscreen receiver in the Dexcom G5 Mobile Glucose Monitoring System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23